Endometrial tumor invasiveness is related to metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expressions
Authors:
- 1 September 2006
- journal article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 16 (5) , 1911-1917
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Metaanalysis of the significance of matrix metalloproteinases for lymph node disease in patients with head and neck squamous cell carcinomaCancer, 2005
- Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinaseInternational Journal of Cancer, 2004
- Gelatinases A and B (MMP-2 and MMP-9) in endometrial cancer—MMP-9 correlates to the grade and the stageGynecologic Oncology, 2004
- Tumour invasion and matrix metalloproteinasesCritical Reviews in Oncology/Hematology, 2004
- Gene expression profiling of tamoxifen-associated uterine cancers: evidence for two molecular classes of endometrial carcinomaGynecologic Oncology, 2004
- Expression Pattern of Metalloproteinases and Tissue Inhibitors of Matrix-Metalloproteinases in Cycling Human Endometrium1Biology of Reproduction, 2003
- Clinical role of MMP‐2/TIMP‐2 imbalance in hepatocellular carcinomaInternational Journal of Cancer, 2001
- FIGO staging classifications and clinical practice gudelines in the management of gynecologic cancersInternational Journal of Gynecology & Obstetrics, 2000
- Activation of the precursor of gelatinase A/72 kda type IV collagenase/MMP‐2 in lung carcinomas correlates with the expression of membrane‐type matrix metalloproteinase (MT‐MMP) and with lymph node metastasisInternational Journal of Cancer, 1995
- Expression of collagenase‐related metalloproteinase genes in human lung or head and neck tumoursInternational Journal of Cancer, 1991